BridgeMD
New treatment option for Acute Stroke
Official title Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
ClinicalTrials.gov ID: NCT07065929
What this study is testing
- What it's testing
- This study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke. In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of stroke.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years of age
- With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke
- NIHSS score ≥ 5
- Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients
- Stroke less than 2 days old
You likely can't join if
- Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as...
- In a palliative situation where life expectancy is \< 3 months
- Patient taking part in another study with an impact on mortality or nutrition
- Previous inclusion in the trial
- Pregnant, breast-feeding or parturient woman
- Patient unable to follow the protocol for any reason
See the full eligibility criteria
- Patients ≥ 18 years of age
- With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke
- NIHSS score ≥ 5
- Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients
- Stroke less than 2 days old
- Anticipated length of hospital stay in a participating centre ≥ 5 days
- Patient affiliated to or benefiting from a social security scheme
- Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives
- Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.).
- In a palliative situation where life expectancy is \< 3 months
- Patient taking part in another study with an impact on mortality or nutrition
- Previous inclusion in the trial
- Pregnant, breast-feeding or parturient woman
- Patient unable to follow the protocol for any reason
- Patient deprived of liberty by judicial or administrative decision
- Patient under compulsory psychiatric care
- Person under legal protection
- Poor understanding of the French language
The study team makes the final eligibility decision.
Where it's taking place
- Chesnay, Yvelines, France
- Angers, France
- Caen, France
- Cholet, France
- La Roche-sur-Yon, France
- La Rochelle, France
- Le Coudray, France
- Rouen, France
- Saint-Herblain, France
- St-Malo, France
- Toulouse, France
- Tours, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chesnay, Yvelines, France; Angers, France; Caen, France; Cholet, France; La Roche-sur-Yon, France; La Rochelle, France and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.